Table 3.
Characteristics and class assignment of the 117 Test Set samples.
| UPN | Cell Source | Time | Blasts % | Dilution | QCC | Real Class | Assigned Class | Confidence |
|---|---|---|---|---|---|---|---|---|
| NB4 | BM | Diagnosis | 100 | No Dilution | OK | APLs Test Set | APLs | 10.802 |
| NB4 | BM | Diagnosis | 100 | No Dilution | OK | APLs Test Set | APLs | 17.507 |
| UPN53 | BM | Diagnosis | 43 | Dilution 50% | OK | APLs Test Set | APLs | 26.028 |
| UPN22 | BM | Diagnosis | 40 | Dilution 50% | OK | APLs Test Set | APLs | 29.91 |
| UPN65 | BM | Diagnosis | 39 | Dilution 50% | OK | APLs Test Set | APLs | 26.403 |
| UPN40 | BM | Diagnosis | 33 | Dilution 50% | OK | APLs Test Set | APLs | 29.91 |
| UPN50 | PB | Diagnosis | 27 | Dilution 50% | OK | APLs Test Set | APLs | 19.2 |
| UPN53 | BM | Diagnosis | 22 | Dilution 75% | OK | APLs Test Set | APLs | 20.904 |
| UPN22 | BM | Diagnosis | 20 | Dilution 75% | OK | APLs Test Set | APLs | 29.91 |
| UPN65 | BM | Diagnosis | 20 | Dilution 75% | OK | APLs Test Set | APLs | 15.763 |
| UPN40 | BM | Diagnosis | 16 | Dilution 75% | OK | APLs Test Set | APLs | 26.425 |
| UPN5 | PB | Diagnosis | 15 | No Dilution | OK | APLs Test Set | APLs | 17.193 |
| UPN50 | PB | Diagnosis | 14 | Dilution 75% | OK | APLs Test Set | APLs | 10.46 |
| UPN48 | PB | Diagnosis | 11 | No Dilution | OK | APLs Test Set | APLs | 23.005 |
| UPN53 | BM | Diagnosis | 9 | Dilution 90% | OK | APLs Test Set | APLs | 16.749 |
| UPN22 | BM | Diagnosis | 8 | Dilution 90% | OK | APLs Test Set | APLs | 15.781 |
| UPN40 | BM | Diagnosis | 7 | Dilution 90% | OK | APLs Test Set | APLs | 10.143 |
| UPN86 | PB | Diagnosis | 7 | No Dilution | OK | APLs Test Set | APLs | 11.641 |
| UPN50 | PB | Diagnosis | 6 | Dilution 90% | OK | APLs Test Set | APLs | 2.661 |
| UPN22 | BM | Diagnosis | 4 | Dilution 95% | OK | APLs Test Set | APLs | 7.665 |
| UPN53 | BM | Diagnosis | 4 | Dilution 95% | OK | APLs Test Set | APLs | 1.201 |
| UPN40 | BM | Diagnosis | 3 | Dilution 95% | OK | APLs Test Set | APLs | 10.667 |
| UPN50 | PB | Diagnosis | 3 | Dilution 95% | OK | APLs Test Set | APLs | 4.337 |
| UPN59 | PB | Diagnosis | 70 | No Dilution | Low RIN | APLs Test Set | APLs | 26.497 |
| UPN82 | BM | Diagnosis | 64 | No Dilution | Low RIN | APLs Test Set | APLs | 22.822 |
| UPN13 | BM | Diagnosis | 30 | No Dilution | Low cRNA | APLs Test Set | APLs | 18.651 |
| Kasumi-1 | BM | Diagnosis | 100 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 5.184 |
| Kasumi-1 | BM | Diagnosis | 100 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 1.525 |
| UPN30 | PB | Diagnosis | 49 | Dilution 50% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 19.199 |
| UPN69 | PB | Diagnosis | 41 | Dilution 50% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 30.674 |
| UPN51 | BM | Relapse | 38 | Dilution 50% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 20.609 |
| UPN76 | PB | Diagnosis | 31 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 32.067 |
| UPN69 | BM | Diagnosis | 30 | Dilution 50% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 25.183 |
| UPN26 | BM | Diagnosis | 27 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 14.89 |
| UPN30 | PB | Diagnosis | 25 | Dilution 75% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 17.719 |
| UPN61 | BM | Diagnosis | 24 | Dilution 50% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 30.674 |
| UPN69 | PB | Diagnosis | 21 | Dilution 75% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 27.738 |
| UPN21 | BM | Diagnosis | 21 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 24.116 |
| UPN95 | BM | Diagnosis | 20 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 30.674 |
| UPN51 | BM | Relapse | 19 | Dilution 75% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 10.519 |
| UPN94 | PB | Diagnosis | 16 | No Dilution | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 28.631 |
| UPN69 | BM | Diagnosis | 15 | Dilution 75% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 22.744 |
| UPN30 | PB | Diagnosis | 10 | Dilution 90% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 16.958 |
| UPN69 | PB | Diagnosis | 6 | Dilution 90% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 13.468 |
| UPN30 | PB | Diagnosis | 5 | Dilution 95% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 13.581 |
| UPN61 | BM | Diagnosis | 5 | Dilution 90% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 28.443 |
| UPN51 | BM | Diagnosis | 4 | Dilution 90% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 3.096 |
| UPN69 | PB | Diagnosis | 3 | Dilution 95% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 12.875 |
| UPN51 | BM | Diagnosis | 2 | Dilution 95% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 4.6 |
| UPN61 | BM | Diagnosis | 2 | Dilution 95% | OK | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 19.237 |
| UPN30 | PB | Diagnosis | 25 | No Dilution | Low cRNA | t(8;21)-AMLs Test Set | t(8;21)-AMLs | 15.256 |
| ME-1 | BM | Diagnosis | 100 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 15.836 |
| ME-1 | BM | Diagnosis | 100 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 18.901 |
| UPN52 | BM | Diagnosis | 56 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 26.467 |
| UPN45 | BM | Diagnosis | 50 | Dilution 50% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 30.188 |
| UPN31 | BM | Diagnosis | 50 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 29.511 |
| UPN88 | BM | Diagnosis | 46 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 31.576 |
| UPN47 | BM | Diagnosis | 41 | Dilution 50% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 30.517 |
| UPN37 | BM | Diagnosis | 40 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 28.551 |
| UPN9 | BM | Diagnosis | 35 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 31.083 |
| UPN87 | PB | Diagnosis | 35 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 29.511 |
| UPN10 | BM | Diagnosis | 33 | Dilution 50% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 17.561 |
| UPN43 | PB | Diagnosis | 31 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 24.289 |
| UPN52 | BM | Diagnosis | 28 | Dilution 50% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 24.608 |
| UPN45 | BM | Diagnosis | 25 | Dilution 75% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 23.687 |
| UPN67 | PB | Diagnosis | 24 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 31.576 |
| UPN36 | PB | Diagnosis | 23 | No Dilution | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 27.432 |
| UPN47 | BM | Diagnosis | 20 | Dilution 75% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 16.733 |
| UPN37 | BM | Diagnosis | 20 | Dilution 50% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 26.644 |
| UPN10 | BM | Diagnosis | 16 | Dilution 75% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 10.252 |
| UPN52 | BM | Diagnosis | 14 | Dilution 75% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 6.543 |
| UPN37 | PB | Relapse | 14 | No Dilution | OK | inv(16)-AMLs Test set | t(8;21)-AMLs | 4.33 |
| UPN45 | BM | Diagnosis | 10 | Dilution 90% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 14.568 |
| UPN47 | BM | Diagnosis | 10 | Dilution 90% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 15.298 |
| UPN37 | BM | Diagnosis | 10 | Dilution 75% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 20.423 |
| UPN10 | BM | Diagnosis | 7 | Dilution 90% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 8.479 |
| UPN52 | BM | Diagnosis | 6 | Dilution 90% | OK | inv(16)-AMLs Test set | APLs | 0.6 |
| UPN45 | BM | Diagnosis | 5 | Dilution 95% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 15.056 |
| UPN47 | BM | Diagnosis | 5 | Dilution 95% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 2.293 |
| UPN7 | BM | Relapse | 5 | No Dilution | OK | inv(16)-AMLs Test set | t(8;21)-AMLs | 0.473 |
| UPN10 | BM | Diagnosis | 4 | Dilution 95% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 3.715 |
| UPN52 | BM | Diagnosis | 3 | Dilution 95% | OK | inv(16)-AMLs Test set | inv(16)-AMLs | 3.79 |
| UPN6 | BM | Diagnosis | 74 | No Dilution | Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 27.753 |
| UPN45 | BM | Diagnosis | 25 | No Dilution | Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 31.005 |
| UPN47 | BM | Diagnosis | 20 | No Dilution | Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 26.009 |
| UPN79 | BM | Diagnosis | 47 | No Dilution | Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 29.75 |
| UPN90 | PB | Diagnosis | 9 | No Dilution | Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 2.693 |
| UPN23 | BM | Diagnosis | 27 | No Dilution | Low RIN + Low cRNA | inv(16)-AMLs Test set | inv(16)-AMLs | 24.111 |
| UPN60 | PB | Diagnosis | 50 | No Dilution | OK | NK-AMLs Test Set | inv(16)-AMLs | 0.948 |
| UPN72 | BM | Diagnosis | 49 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 26.707 |
| UPN8 | BM | Diagnosis | 48 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 27.354 |
| UPN44 | PB | Diagnosis | 47 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 28.541 |
| UPN73 | PB | Diagnosis | 47 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 19.624 |
| UPN97 | BM | Diagnosis | 47 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 22.934 |
| UPN1 | PB | Diagnosis | 46 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 26.707 |
| UPN66 | BM | Diagnosis | 46 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 23.454 |
| UPN78 | PB | Diagnosis | 46 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 28.541 |
| UPN25 | BM | Diagnosis | 43 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 21.699 |
| UPN38 | BM | Diagnosis | 40 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 26.707 |
| UPN74 | BM | Diagnosis | 40 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 19.777 |
| UPN89 | BM | Diagnosis | 40 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 29.115 |
| UPN19 | BM | Diagnosis | 39 | No Dilution | OK | NK-AMLs Test Set | NK-AMLs | 25.313 |
| UPN11 | BM | Diagnosis | 37 | Dilution 50% | OK | NK-AMLs Test Set | NK-AMLs | 29.776 |
| UPN96 | PB | Diagnosis | 35 | No Dilution | OK | NK-AMLs Test Set | NK-AMLs | 27.303 |
| UPN72 | BM | Diagnosis | 25 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 26.707 |
| UPN8 | BM | Diagnosis | 24 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 27.357 |
| UPN44 | PB | Diagnosis | 24 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 29.235 |
| UPN97 | BM | Diagnosis | 24 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 24.035 |
| UPN1 | PB | Diagnosis | 23 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 26.707 |
| UPN66 | BM | Diagnosis | 23 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 19 |
| UPN73 | PB | Diagnosis | 23 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 24.104 |
| UPN78 | PB | Diagnosis | 23 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 28.541 |
| UPN25 | BM | Diagnosis | 21 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 18.99 |
| UPN38 | BM | Diagnosis | 20 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 25.107 |
| UPN74 | BM | Diagnosis | 20 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 19.705 |
| UPN89 | BM | Diagnosis | 20 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 26.555 |
| UPN11 | BM | Diagnosis | 19 | Dilution 75% | OK | NK-AMLs Test Set | NK-AMLs | 24.587 |
UPN, unique patient number. BM, bone marrow. PB, peripheral blood. QCC, quality control criteria.
Low cRNA, amount of labeled cRNA hybridized on the BeadChip below 750 ng. Low RIN, RNA integrity number below 7.00.